Berondo, Fred Ivan P.

HRN: 15-29-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2024
CEFUROXIME 750MG (VIAL)
05/27/2024
06/03/2024
IV
500mg
Every 8hours
Empiric
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: